{"id":"https://openalex.org/W2887210902","doi":"https://doi.org/10.1158/1538-7445.am2018-3751","title":"Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models","display_name":"Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2887210902","doi":"https://doi.org/10.1158/1538-7445.am2018-3751","mag":"2887210902"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-3751","doi":"https://doi.org/10.1158/1538-7445.am2018-3751","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-3751","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024258839","display_name":"Alexandra Borodovsky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandra Borodovsky","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100327183","display_name":"Yanjun Wang","orcid":"https://orcid.org/0000-0002-8178-9925","observed_orcids":["https://orcid.org/0000-0002-8178-9925"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanjun Wang","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030065450","display_name":"Minwei Ye","orcid":"https://orcid.org/0000-0002-5994-0529","observed_orcids":["https://orcid.org/0000-0002-5994-0529"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minwei Ye","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Joseph C. Shaw","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph C. Shaw","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044997582","display_name":"Kris F. Sachsenmeier","orcid":"https://orcid.org/0000-0002-5081-8885","observed_orcids":["https://orcid.org/0000-0002-5081-8885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kris Sachsenmeier","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010287617","display_name":"Nanhua Deng","orcid":"https://orcid.org/0000-0003-2356-2105","observed_orcids":["https://orcid.org/0000-0003-2356-2105"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nanhua Deng","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068125442","display_name":"Kelly Goodwin","orcid":"https://orcid.org/0000-0002-6594-1763","observed_orcids":["https://orcid.org/0000-0002-6594-1763"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly Goodwin","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045332430","display_name":"James D. Clarke","orcid":"https://orcid.org/0009-0001-8803-4728","observed_orcids":["https://orcid.org/0009-0001-8803-4728"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James D. Clarke","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024327032","display_name":"Richard J. A. Goodwin","orcid":"https://orcid.org/0000-0001-5699-8488","observed_orcids":["https://orcid.org/0000-0001-5699-8488"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Goodwin","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084595261","display_name":"Nicole Strittmatter","orcid":"https://orcid.org/0000-0003-1277-9608","observed_orcids":["https://orcid.org/0000-0003-1277-9608"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicole Strittmatter","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040979655","display_name":"Carl M. Hay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carl Hay","raw_affiliation_strings":["2MedImmune, Gaithersburg, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MedImmune, Gaithersburg, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055595135","display_name":"Vasu R. Sah","orcid":"https://orcid.org/0000-0002-7897-6156","observed_orcids":["https://orcid.org/0000-0002-7897-6156"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vasu Sah","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084963518","display_name":"Deborah Lawson","orcid":"https://orcid.org/0000-0003-4189-5528","observed_orcids":["https://orcid.org/0000-0003-4189-5528"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawson Deborah","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037780629","display_name":"Corinne Reimer","orcid":"https://orcid.org/0000-0003-3457-1496","observed_orcids":["https://orcid.org/0000-0003-3457-1496"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Corinne Reimer","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081802485","display_name":"Miles Congreve","orcid":"https://orcid.org/0000-0003-1913-0318","observed_orcids":["https://orcid.org/0000-0003-1913-0318"]},"institutions":[{"id":"https://openalex.org/I4210147697","display_name":"Heptares Therapeutics (United Kingdom)","ror":"https://ror.org/051fk5x88","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147697"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Miles Congreve","raw_affiliation_strings":["3Heptares Therapeutics, Hertfordshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Heptares Therapeutics, Hertfordshire, United Kingdom","institution_ids":["https://openalex.org/I4210147697"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107412290","display_name":"Jonathan S. Mason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147697","display_name":"Heptares Therapeutics (United Kingdom)","ror":"https://ror.org/051fk5x88","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147697"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan Mason","raw_affiliation_strings":["3Heptares Therapeutics, Hertfordshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Heptares Therapeutics, Hertfordshire, United Kingdom","institution_ids":["https://openalex.org/I4210147697"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016565466","display_name":"Fiona H. Marshall","orcid":"https://orcid.org/0000-0002-8681-005X","observed_orcids":["https://orcid.org/0000-0002-8681-005X"]},"institutions":[{"id":"https://openalex.org/I4210147697","display_name":"Heptares Therapeutics (United Kingdom)","ror":"https://ror.org/051fk5x88","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210147697"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Fiona Marshall","raw_affiliation_strings":["3Heptares Therapeutics, Hertfordshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Heptares Therapeutics, Hertfordshire, United Kingdom","institution_ids":["https://openalex.org/I4210147697"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016791761","display_name":"Paul D. Lyne","orcid":"https://orcid.org/0000-0003-0861-9134","observed_orcids":["https://orcid.org/0000-0003-0861-9134"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Lyne","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013946717","display_name":"Richard D. Woessner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Woessner","raw_affiliation_strings":["1AstraZeneca, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca, Boston, MA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"3751","last_page":"3751"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-signaling","display_name":"adenosine signaling","score":0.8420000076293945},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.7179999947547913},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9259999990463257},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6710000038146973},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7979999780654907},{"id":"https://openalex.org/keywords/spatial-heterogeneity","display_name":"spatial heterogeneity","score":0.8500000238418579},{"id":"https://openalex.org/keywords/cd8-t-cell-infiltration","display_name":"CD8+ T cell infiltration","score":0.9570000171661377},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5950000286102295},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.7300000190734863}],"concepts":[{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.8246873617172241},{"id":"https://openalex.org/C2778491162","wikidata":"https://www.wikidata.org/wiki/Q3063865","display_name":"Adenosine A2A receptor","level":5,"score":0.5495147705078125},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5119415521621704},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.5001523494720459},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4963887333869934},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48280560970306396},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47259292006492615},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46548381447792053},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4101765751838684},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26080435514450073},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2465531826019287},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21892625093460083},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18852463364601135},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-3751","doi":"https://doi.org/10.1158/1538-7445.am2018-3751","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-3751","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2739770219","https://openalex.org/W3012213271","https://openalex.org/W3045994471","https://openalex.org/W3134422943","https://openalex.org/W4253836784","https://openalex.org/W4306152136","https://openalex.org/W4232664856","https://openalex.org/W4379984587","https://openalex.org/W2740653681","https://openalex.org/W4415898572"],"abstract_inverted_index":{"Abstract":[0],"Adenosine":[1],"signaling":[2,79,228,281],"through":[3],"the":[4,27,71,93,106,250,256,359],"high":[5],"affinity":[6],"adenosine":[7,83,109,119,133,147,155,166,185,220],"2A":[8],"receptor":[9],"(A2AR)":[10],"on":[11,82,110],"immune":[12,30],"cells":[13],"elicits":[14],"a":[15,36,45,51,125,136,143,180,211,233,271],"range":[16,145],"of":[17,29,73,77,95,105,108,117,131,138,146,153,179,199,213,226,259,279,339,358],"immunosuppressive":[18],"effects":[19],"which":[20],"can":[21,288],"promote":[22],"tumor":[23,140,216,238,290],"growth":[24,239],"and":[25,38,54,85,121,203,241,262,273,292,347],"limit":[26],"efficacy":[28],"checkpoint":[31,245],"inhibitors.":[32,246],"AZD4635":[33,74,111,230,269,287,342],"(HTL-1071)":[34],"is":[35,80,270],"potent":[37,272],"selective":[39,274],"oral":[40],"A2AR":[41,78,200,227,275,280,340],"antagonist,":[42],"currently":[43],"in":[44,55,61,68,92,135,194,204,210,237,242,255,348,352],"Phase":[46],"1":[47],"clinical":[48],"trial":[49],"as":[50,286],"single":[52,181],"agent":[53],"combination":[56,205,243,349],"with":[57,63,171,189,206,218,229,244,282,350],"durvalumab":[58],"(anti-PD-L1":[59],"Ab)":[60],"patients":[62],"solid":[64],"malignancies.":[65],"In":[66,222],"functional":[67,257],"vitro":[69],"assays,":[70],"IC50":[72],"for":[75,362],"inhibition":[76,225],"dependent":[81,235],"concentrations":[84,134,186],"ranges":[86],"from":[87,249],"1,":[88,97],"10.0,":[89],"143":[90],"nM":[91],"presence":[94],"0.1,":[96],"10":[98],"\u03bcM":[99],"adenosine,":[100],"respectively.":[101],"However,":[102],"full":[103],"understanding":[104],"impact":[107],"mediated":[112],"anti-tumor":[113,344],"responses":[114],"requires":[115],"characterization":[116],"intratumoral":[118,132,154,184,191],"concentration":[120],"spatial":[122],"heterogeneity.":[123],"Using":[124],"novel":[126],"LC/MS":[127],"based":[128],"method,":[129],"measurement":[130,152],"panel":[137,212],"syngeneic":[139,214],"models":[141,217,354],"demonstrated":[142,164],"wide":[144],"levels":[148,167,172],"(5-122":[149],"\u03bcM).":[150],"Additionally,":[151],"by":[156,341],"desorption":[157],"electrospray":[158],"ionisation":[159],"-":[160],"mass":[161],"spectroscopy":[162],"(DESI-MS)":[163],"that":[165,268,277],"are":[168],"spatially":[169],"heterogeneous,":[170],"varying":[173,219],"up":[174],"to":[175,232],"50-fold":[176],"among":[177],"regions":[178],"tumor.":[182],"High":[183],"were":[187],"correlated":[188],"decreased":[190],"CD8":[192],"infiltration":[193],"vivo.":[195],"The":[196],"therapeutic":[197],"benefit":[198],"blockade":[201,278],"alone":[202,240,346],"anti-PD-L1":[207,351],"was":[208],"evaluated":[209],"mouse":[215],"concentrations.":[221],"sensitive":[223],"models,":[224],"led":[231],"dose":[234],"reduction":[236],"Tumors":[247],"harvested":[248],"treated":[251],"mice":[252],"exhibited":[253],"increases":[254],"activity":[258],"T":[260],"cell":[261],"myeloid":[263],"subsets.":[264],"These":[265],"results":[266],"demonstrate":[267],"inhibitor,":[276],"an":[283],"inhibitor":[284],"such":[285],"reduce":[289],"burden":[291],"enhance":[293],"antitumor":[294],"immunity.":[295],"Citation":[296],"Format:":[297],"Alexandra":[298],"Borodovsky,":[299],"Yanjun":[300],"Wang,":[301],"Minwei":[302],"Ye,":[303],"Joseph":[304],"C.":[305],"Shaw,":[306],"Kris":[307],"Sachsenmeier,":[308],"Nanhua":[309],"Deng,":[310],"Kelly":[311],"Goodwin,":[312,317],"James":[313],"D.":[314],"Clarke,":[315],"Richard":[316,336],"Nicole":[318],"Strittmatter,":[319],"Carl":[320],"Hay,":[321],"Vasu":[322],"Sah,":[323],"Lawson":[324],"Deborah,":[325],"Corinne":[326],"Reimer,":[327],"Miles":[328],"Congreve,":[329],"Jonathan":[330],"Mason,":[331],"Fiona":[332],"Marshall,":[333],"Paul":[334],"Lyne,":[335],"Woessner.":[337],"Inhibition":[338],"induces":[343],"immunity":[345],"preclinical":[353],"[abstract].":[355],"In:":[356],"Proceedings":[357],"American":[360],"Association":[361],"Cancer":[363,376],"Research":[364],"Annual":[365],"Meeting":[366],"2018;":[367],"2018":[368],"Apr":[369],"14-18;":[370],"Chicago,":[371],"IL.":[372],"Philadelphia":[373],"(PA):":[374],"AACR;":[375],"Res":[377],"2018;78(13":[378],"Suppl):Abstract":[379],"nr":[380],"3751.":[381]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2018-08-22T00:00:00"}